Analyst Price Targets — ZBH
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 12, 2026 1:04 pm | Matt Miksic | Barclays | $100.00 | $96.69 | TheFly | Zimmer Biomet price target lowered to $100 from $104 at Barclays |
| February 11, 2026 2:08 pm | — | UBS | $89.00 | $93.69 | TheFly | Zimmer Biomet price target raised to $89 from $86 at UBS |
| January 28, 2026 1:09 pm | — | UBS | $86.00 | $85.27 | TheFly | Zimmer Biomet price target lowered to $86 from $88 at UBS |
| January 9, 2026 11:51 am | — | Bernstein | $99.00 | $94.08 | TheFly | Zimmer Biomet price target raised to $99 from $97 at Bernstein |
| January 9, 2026 10:44 am | David Roman | Goldman Sachs | $93.00 | $94.08 | TheFly | Zimmer Biomet downgraded to Sell from Neutral at Goldman Sachs |
| January 5, 2026 11:19 am | — | Evercore ISI | $120.00 | $90.02 | TheFly | Zimmer Biomet upgraded to Outperform from In Line at Evercore ISI |
| December 16, 2025 10:21 am | Jeff Johnson | Robert W. Baird | $100.00 | $92.52 | TheFly | Zimmer Biomet downgraded to Neutral from Outperform at Baird |
| November 5, 2025 6:25 pm | Rick Wise | Stifel Nicolaus | $110.00 | $87.91 | TheFly | Zimmer Biomet price target lowered to $110 from $118 at Stifel |
| November 5, 2025 4:32 pm | — | Johnson Rice | $112.00 | $88.05 | TheFly | Zimmer Biomet price target lowered to $112 from $122 at BTIG |
| November 5, 2025 11:27 am | — | Barclays | $105.00 | $103.18 | TheFly | Zimmer Biomet price target lowered to $105 from $112 at Barclays |
Latest News for ZBH
Citigroup Inc. lowered its position in shares of Zimmer Biomet Holdings, Inc. (NYSE: ZBH) by 14.8% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 145,608 shares of the medical equipment provider's stock after selling 25,334 shares during the quarter. Citigroup Inc.
Company's Chief Movement Officer, Arnold Schwarzenegger,Will Be Presidential Guest Speaker WARSAW, Ind., Feb. 25, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced it will unveil new clinical and operational data and showcase its newest innovations at the American Academy of Orthopaedic Surgeons (AAOS) 2026 Annual Meeting.
WARSAW, Ind., Feb. 23, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the first quarter of 2026.
Partner Reed Kathrein Scrutinizing ZBH's "High Confidence" Assurances After 15% Stock Collapse and Reduced Revenue Guidance SAN FRANCISCO, Feb. 18, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman is investigating Zimmer Biomet Holdings, Inc. (NYSE: ZBH) following a series of disclosures that calls into question the reasonable basis for the company's previously expressed "high confidence" in…
ABN Amro Investment Solutions trimmed its holdings in shares of Zimmer Biomet Holdings, Inc. (NYSE: ZBH) by 31.6% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 23,860 shares of the medical equipment provider's stock after selling
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.